Symbol="KROS"
AssetType="Common Stock"
Name="Keros TherapeuticsÂ Inc"
Description="Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with a great unmet medical need. The company is headquartered in Lexington, Massachusetts."
CIK="1664710"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="99 HAYDEN AVENUE, SUITE 120 (BLD E), LEDGEMONT TECHNOLOGY CENTER, LEXINGTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1075682000"
EBITDA="-128805000"
PERatio="None"
PEGRatio="None"
BookValue="10.07"
DividendPerShare="0"
DividendYield="0"
EPS="-4.43"
RevenuePerShareTTM="0.824"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.261"
ReturnOnEquityTTM="-0.402"
RevenueTTM="20000000"
GrossProfitTTM="-87265000"
DilutedEPSTTM="-4.43"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="90.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="68.42"
PriceToBookRatio="5.74"
EVToRevenue="57.24"
EVToEBITDA="-14.45"
Beta="1.083"
num_52WeekHigh="59.96"
num_52WeekLow="33.11"
num_50DayMovingAverage="41.79"
num_200DayMovingAverage="46.45"
SharesOutstanding="29584200"
DividendDate="None"
ExDividendDate="None"
symbol="KROS"
open="36.55"
high="37.79"
low="36.07"
price="36.65"
volume="110740.00"
latest_trading_day="2023-08-10"
previous_close="36.36"
change="0.29"
change_percent="0.7976%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="91"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="9"
Volume_recent_avg="200573"
Change_recent_avg="-0.08"
Delta_recent_avg="2.12"
Variance_recent_avg="1.06"
Change_ratio_recent_avg="-0.24"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="9"
Aroon_momentum_negative="91"
image_negative_thumbnail_id_1="518"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0087.jpeg"
image_negative_thumbnail_id_2="149"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0027.jpeg"
image_neutral_thumbnail_id_1="533"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_neutral_thumbnail_id_2="532"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_positive_thumbnail_id_1="984"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_positive_thumbnail_id_2="999"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0161.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
